Evidence map›Paper›PMID 23173892›Full record

ReviewSeminars in dialysis

Optimal hemodialysis vascular access in the elderly patient.

Louise M Moist, Charmaine E Lok, Tushar J Vachharajani, Wang Xi, Ahmed AlJaishi, Kevan R Polkinghorne, Miguel Vazquez, Timmy C Lee

Abstract readReview
In one paragraph

Review in Seminars in dialysis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 101 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. The challenging surgical vascular access creation.Cardiovascular diagnosis and therapy · 2023
    Review
  11. Surgical creation of lower extremity fistula and grafts.Cardiovascular diagnosis and therapy · 2023
    Review
  12. Article
  13. Review
  14. Article
  15. Nuances of Arteriovenous Fistula Creation for Vascular Access in Hemodialysis.Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India · 2021
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Louise M MoistKidney Clinical Research Unit, Division of Nephrology, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. louise.moist@lhsc.on.ca
Charmaine E Lok
Tushar J Vachharajani
Wang Xi
Ahmed AlJaishi
Kevan R Polkinghorne
Miguel Vazquez
Timmy C Lee
Western University · CAAustralian Regenerative Medicine Institute · AUThe University of Texas Southwestern Medical Center · USUniversity of Cincinnati · USUniversity of Toronto · CAW. G. (Bill) Hefner VA Medical Center · US

Funding

Novel Biological Markers in Impaired Arteriovenous Fistula MaturationK23DK083528 · NIDDK · UNIVERSITY OF CINCINNATI · PI LEE, TIMMY C · 2009 to 2013
$843k
NIDDK NIH HHS K23 DK083528
6 · The paper itself

Abstract

The optimal vascular access for elderly patients remains a challenge due to the difficulty balancing the benefits and risks in a population with increased comorbidity and decreased survival. Age is commonly associated with failure to mature in fistula and decreased rates of primary and secondary patency in both fistula and grafts. In the elderly, at 1 and 2 years, primary patency rates range from 43% to 74% and from 29% to 67%, respectively. Secondary patency rates at 1 and 2 years range from 56% to 82% and 44% to 67%, respectively. Cumulative fistula survival is no better than grafts survival when primary failures are included. Several observational studies consistently demonstrate a lower adjusted mortality among those using a fistula compared with a catheter; however, catheter use in the elderly is increasing in most countries with the exception of Japan. Both guidelines and quality initiatives do not acknowledge the trade-offs involved in managing the elderly patients with multiple chronic conditions and limited life expectancy or the value that patients place on achieving these outcomes. The framework for choice of vascular access presented in this article considers: (1) likelihood of disease progression before death, (2) patient life expectancy, (3) risks and benefits by vascular access type, and (4) patient preference. Future studies evaluating the timing and type of vascular access with careful assessments of complications, functionality, cost benefit, and patients' preference will provide relevant information to individualize and optimize care to improve morbidity, mortality, and quality of life in the elderly patient.

Indexed as

Arteriovenous Shunt, SurgicalCatheters, IndwellingRenal DialysisAgedDecision MakingDisease ProgressionHumansKidney Failure, ChronicLife ExpectancyPatient Preference

Identifiers

PMID23173892
PMCPMC3999348
OpenAlexW1789494675

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.